Scientists cover the recent advancements in the identification of proteomic/genomic/epigenomic/transcriptomic biomarkers for predicting hepatocellular carcinoma treatment efficacy with the use of multi-kinase inhibitors, CDK4/6 inhibitors, and immune checkpoint inhibitors.
[Expert Review of Molecular Diagnostics]
7992332
{7992332:AAAAAAAA}
apa
50
1
167311
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
